Title : Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE.

Pub. Date : 2017 Oct 15

PMID : 28651842






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE. glucuronyl glucosamine glycan sulfate mitochondrially encoded cytochrome c oxidase II Homo sapiens
2 We tested the hypothesis that sulodexide (SDX), a highly purified glycosaminoglycan composed of 80% iduronylglycosaminoglycan sulfate and 20% dermatan sulfate, protects human retinal endothelial cells (HREC) from high glucose (HG)-induced damage, through the suppression of inflammatory ERK/cPLA2/COX-2/PGE2 pathway, by blocking the effect of advanced glycation end-products (AGEs). glucuronyl glucosamine glycan sulfate mitochondrially encoded cytochrome c oxidase II Homo sapiens
3 We tested the hypothesis that sulodexide (SDX), a highly purified glycosaminoglycan composed of 80% iduronylglycosaminoglycan sulfate and 20% dermatan sulfate, protects human retinal endothelial cells (HREC) from high glucose (HG)-induced damage, through the suppression of inflammatory ERK/cPLA2/COX-2/PGE2 pathway, by blocking the effect of advanced glycation end-products (AGEs). glucuronyl glucosamine glycan sulfate mitochondrially encoded cytochrome c oxidase II Homo sapiens
4 These data show that SDX protects HREC from HG damage and suggest that it counteracts the activation of ERK/cPLA2/COX-2/PGE2 pathway by reducing AGE-related signaling and downstream NFkappaB activity. glucuronyl glucosamine glycan sulfate mitochondrially encoded cytochrome c oxidase II Homo sapiens